Injectable Drug Delivery Devices Market Analysis

  • Report ID: 3277
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Injectable Drug Delivery Devices Market Analysis

The global injectable drug delivery devices market is segmented on the basis of product into conventional injection devices, and advanced injection devices, out of which, the advanced injection devices segment is expected to grab the largest market share in the forecast period, on the back of its advantages, such as, convenient application and low healthcare cost. 

Based on end-user, the hospital & clinics segment is expected to gain largest share in terms of revenue, on the back of increasing patient influx and longer stay of the patients at the hospitals suffering from chronic diseases.  

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3277
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of injectable drug delivery devices is assessed at USD 130.64 billion.

Injectable Drug Delivery Devices Market size was over USD 123.2 billion in 2024 and is projected to reach USD 300.52 billion by 2037, growing at around 7.1% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is set to dominate majority revenue share by 2037, propelled by increasing incidence of chronic disorders in the region.

The major players in the market are Baxter International Inc., Eli Lilly and Company, West Pharmaceutical Services Inc., Pfizer Inc., Schott AG, and others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample